News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
457,108 Results
Type
Article (24814)
Company Profile (146)
Press Release (432148)
Multimedia
Podcasts (30)
Webinars (8)
Section
Business (124955)
Career Advice (455)
Deals (20503)
Drug Delivery (42)
Drug Development (79234)
Employer Resources (46)
FDA (12594)
Job Trends (9353)
News (234568)
Policy (18812)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (2)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 Biotech Bay Standard (1)
Academia (1738)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (77)
Alliances (33804)
ALS (91)
Alzheimer's disease (1343)
Antibody-drug conjugate (ADC) (110)
Approvals (12592)
Artificial intelligence (228)
Autoimmune disease (19)
Automation (10)
Bankruptcy (148)
Best Places to Work (8203)
BIOSECURE Act (11)
Biosimilars (65)
Biotechnology (113)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (255)
Cancer (2003)
Cardiovascular disease (156)
Career advice (397)
Career pathing (14)
CAR-T (143)
Cell therapy (378)
Cervical cancer (20)
Clinical research (65676)
Collaboration (663)
Compensation (386)
Complete response letters (22)
COVID-19 (2062)
CRISPR (31)
C-suite (188)
Cystic fibrosis (91)
Data (2013)
Decentralized trials (2)
Denatured (16)
Depression (42)
Diabetes (219)
Diagnostics (5114)
Digital health (13)
Diversity (8)
Diversity, equity & inclusion (19)
Drug discovery (100)
Drug pricing (25)
Drug shortages (10)
Duchenne muscular dystrophy (81)
Earnings (47565)
Editorial (18)
Employer branding (3)
Employer resources (44)
Events (73233)
Executive appointments (569)
FDA (13653)
Featured Employer (22)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (616)
Gene editing (89)
Generative AI (22)
Gene therapy (257)
GLP-1 (526)
Government (2294)
Grass and pollen (3)
Guidances (36)
Healthcare (13837)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (101)
Indications (26)
Infectious disease (2174)
Inflammatory bowel disease (136)
Inflation Reduction Act (3)
Influenza (43)
Intellectual property (75)
Interviews (62)
IPO (10930)
IRA (8)
Job creations (1517)
Job search strategy (358)
Kidney cancer (10)
Labor market (17)
Layoffs (286)
Leadership (6)
Legal (2371)
Liver cancer (62)
Lung cancer (297)
Lymphoma (130)
Machine learning (4)
Management (14)
Manufacturing (177)
MASH (57)
Medical device (9255)
Medtech (9255)
Mergers & acquisitions (10040)
Metabolic disorders (524)
Multiple sclerosis (71)
NASH (14)
Neurodegenerative disease (87)
Neuropsychiatric disorders (19)
Neuroscience (1829)
NextGen: Class of 2025 (3933)
Non-profit (2489)
Northern California (2247)
Now hiring (19)
Obesity (255)
Opinion (144)
Ovarian cancer (69)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (144)
Partnered (13)
Patents (163)
Patient recruitment (101)
Peanut (43)
People (38178)
Pharmaceutical (35)
Pharmacy benefit managers (1)
Phase I (21144)
Phase II (29274)
Phase III (21211)
Pipeline (1013)
Policy (37)
Postmarket research (2059)
Preclinical (7570)
Press Release (29)
Prostate cancer (92)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (335)
Real estate (2928)
Recruiting (16)
Regulatory (15827)
Reports (24)
Research institute (1855)
Resumes & cover letters (61)
Rett syndrome (4)
RNA editing (4)
RSV (26)
Schizophrenia (60)
Series A (113)
Series B (78)
Service/supplier (8)
Sickle cell disease (42)
Southern California (1928)
Special edition (12)
Spinal muscular atrophy (143)
Sponsored (16)
Startups (2418)
State (1)
Stomach cancer (12)
Supply chain (34)
Tariffs (3)
The Weekly (14)
United States (18143)
Vaccines (476)
Venture capitalists (23)
Weight loss (136)
Women's health (31)
Worklife (7)
Date
Today (13)
Last 7 days (391)
Last 30 days (1995)
Last 365 days (27550)
2025 (7729)
2024 (29379)
2023 (33262)
2022 (41156)
2021 (43153)
2020 (39754)
2019 (30861)
2018 (23244)
2017 (23949)
2016 (21948)
2015 (25647)
2014 (18528)
2013 (13926)
2012 (14584)
2011 (14975)
2010 (14088)
Location
Africa (371)
Alabama (43)
Alaska (4)
Arizona (118)
Arkansas (8)
Asia (27754)
Australia (5451)
California (5023)
Canada (1491)
China (436)
Colorado (217)
Connecticut (224)
Delaware (110)
Europe (63399)
Florida (671)
Georgia (170)
Idaho (38)
Illinois (319)
India (15)
Indiana (227)
Iowa (4)
Japan (126)
Kansas (77)
Kentucky (21)
Louisiana (6)
Maine (25)
Maryland (635)
Massachusetts (3704)
Michigan (128)
Minnesota (234)
Mississippi (1)
Missouri (54)
Montana (27)
Nebraska (16)
Nevada (43)
New Hampshire (52)
New Jersey (1336)
New Mexico (22)
New York (1407)
North Carolina (786)
North Dakota (4)
Northern California (2247)
Ohio (144)
Oklahoma (13)
Oregon (29)
Pennsylvania (1097)
Puerto Rico (7)
Rhode Island (18)
South America (491)
South Carolina (14)
Southern California (1928)
Tennessee (72)
Texas (772)
Utah (131)
Virginia (109)
Washington D.C. (40)
Washington State (453)
West Virginia (1)
Wisconsin (34)
457,108 Results for "george clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breathe BioMedical Launches Multi-Center Clinical Trial of its Breath Test for Breast Cancer at George Washington University Breast Center
February 25, 2025
·
3 min read
Press Releases
Dr. Gregory George MD PhD Joins Mesoblast Board
February 24, 2025
·
6 min read
Press Releases
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs
February 4, 2025
·
2 min read
Business
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies announced that translational immunology expert George Vratsanos, M.D., FACR, is joining its board of directors.
June 13, 2024
·
5 min read
Business
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
Calidi Biotherapeutics, Inc. today announced the appointment of Dr. George E. Peoples, MD, FACS, to the company’s Board of Directors, effective July 1, 2024.
June 27, 2024
·
4 min read
Press Releases
Emily Whitehead Foundation Names George Eastwood Executive Director, Darshan Kulkarni Board Chair
January 30, 2025
·
3 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central America
January 15, 2025
·
6 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
January 14, 2025
·
6 min read
Business
Mythic Therapeutics Appoints George Eliades, Ph.D., as President and Chief Executive Officer
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the company as President and Chief Executive Officer (CEO).
March 28, 2024
·
2 min read
Business
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
George Medicines announces the appointment of Mark Mallon as its new Chief Executive Officer and Board Director, effective immediately.
April 29, 2024
·
3 min read
1 of 45,711
Next
